157 related articles for article (PubMed ID: 33206840)
21. Neonatal outcome of small for gestational age preterm infants.
Nobile S; Marchionni P; Carnielli VP
Eur J Pediatr; 2017 Aug; 176(8):1083-1088. PubMed ID: 28660312
[TBL] [Abstract][Full Text] [Related]
22. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
[No Abstract] [Full Text] [Related]
25. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
[TBL] [Abstract][Full Text] [Related]
26. [Failure of non-invasive continuous positive airway pressure as the initial respiratory support in very preterm infants: a multicenter prospective cohort study].
Multicenter Study Collaborative Group for Evaluation of Outcomes in Very Low Birth Weight Infants
Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):273-279. PubMed ID: 33775045
[No Abstract] [Full Text] [Related]
27. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial.
Gortner L; Wauer RR; Hammer H; Stock GJ; Heitmann F; Reiter HL; Kühl PG; Möller JC; Friedrich HJ; Reiss I; Hentschel R; Jorch G; Hieronimi G; Kuhls E
Pediatrics; 1998 Nov; 102(5):1153-60. PubMed ID: 9794948
[TBL] [Abstract][Full Text] [Related]
28. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.
Sankar MJ; Gupta N; Jain K; Agarwal R; Paul VK
J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S36-48. PubMed ID: 27109091
[TBL] [Abstract][Full Text] [Related]
30. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
[No Abstract] [Full Text] [Related]
32. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
33. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll R; Wiswell TE
Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
[TBL] [Abstract][Full Text] [Related]
34. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
[TBL] [Abstract][Full Text] [Related]
35. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
Soll R; Ozek E
Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
[TBL] [Abstract][Full Text] [Related]
36. Sustained lung inflation at birth via short binasal prong in very low birth weight preterm infants: A retrospective study.
Buyuktiryaki M; Kanmaz HG; Okur N; Bezirganoglu H; Ozer Bekmez B; Simsek GK; Canpolat FE; Oguz SS; Tayman C
Pediatr Pulmonol; 2018 Oct; 53(10):1407-1413. PubMed ID: 29999603
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for early death among extremely low-birth-weight infants.
Shankaran S; Fanaroff AA; Wright LL; Stevenson DK; Donovan EF; Ehrenkranz RA; Langer JC; Korones SB; Stoll BJ; Tyson JE; Bauer CR; Lemons JA; Oh W; Papile LA
Am J Obstet Gynecol; 2002 Apr; 186(4):796-802. PubMed ID: 11967510
[TBL] [Abstract][Full Text] [Related]
38. Continuous distending pressure for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
[TBL] [Abstract][Full Text] [Related]
39. Goat lung surfactant for treatment of respiratory distress syndrome among preterm neonates: a multi-site randomized non-inferiority trial.
Jain K; Nangia S; Ballambattu VB; Sundaram V; Sankar MJ; Ramji S; Vishnubhatla S; Thukral A; Gupta YK; Plakkal N; Sundaram M; Jajoo M; Kumar P; Jayaraman K; Jain A; Saili A; Murugesan A; Chawla D; Murki S; Nanavati R; Rao S; Vaidya U; Mehta A; Arora K; Mondkar J; Arya S; Bahl M; Utture A; Manerkar S; Bhat SR; Parikh T; Kumar M; Bajpai A; Sivanandan S; Dhawan PK; Vishwakarma G; Bangera S; Kumar S; Gopalakrishnan S; Jindal A; Natarajan CK; Saini A; Karunanidhi S; Malik M; Narang P; Kaur G; Yadav CP; Deorari A; Paul VK; Agarwal R
J Perinatol; 2019 Sep; 39(Suppl 1):3-12. PubMed ID: 31485014
[TBL] [Abstract][Full Text] [Related]
40. Surfactant utilization and short-term outcomes in an era of non-invasive respiratory support in Canadian neonatal intensive care units.
Raghuram K; Mukerji A; Young J; Yee W; Seshia M; Dow K; Shah V
J Perinatol; 2017 Sep; 37(9):1017-1023. PubMed ID: 28661515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
